Wholeleaf is addressing the rapidly growing chronic and neuropathic pain market with CBD-based Ayurvedic solutions.
It offers clinically validated oral tinctures and topical products positioned as safer alternatives to conventional pain medications, delivering strong gross margins.
The company is AYUSH licensed, GMP certified, and distributed across 850+ pharmacies, achieving ₹9 Cr ARR with 16× growth in the past 18 months.
Backed by Shark Tank funding and already profitable, Wholeleaf operates through B2C and B2B2C channels supported by strong medical partnerships.
